Watch for Dosing Confusion with Ceftolozane/Tazobactam

Please see the FDA safety warning (May 2015) concerning dose confusion/medication errors associated with Zerbaxa Reps will be promoting a new IV anti-infective, ceftolozane/tazobactam (Zerbaxa). C...

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals